BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1542 related articles for article (PubMed ID: 28880092)

  • 1. Using Peptide Aptamer Targeted Polymers as a Model Nanomedicine for Investigating Drug Distribution in Cancer Nanotheranostics.
    Zhao Y; Houston ZH; Simpson JD; Chen L; Fletcher NL; Fuchs AV; Blakey I; Thurecht KJ
    Mol Pharm; 2017 Oct; 14(10):3539-3549. PubMed ID: 28880092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theranostic pH-sensitive nanoparticles for highly efficient targeted delivery of doxorubicin for breast tumor treatment.
    Pan C; Liu Y; Zhou M; Wang W; Shi M; Xing M; Liao W
    Int J Nanomedicine; 2018; 13():1119-1137. PubMed ID: 29520140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced cancer therapy with pH-dependent and aptamer functionalized doxorubicin loaded polymeric (poly D, L-lactic-co-glycolic acid) nanoparticles.
    Saravanakumar K; Hu X; Shanmugam S; Chelliah R; Sekar P; Oh DH; Vijayakumar S; Kathiresan K; Wang MH
    Arch Biochem Biophys; 2019 Aug; 671():143-151. PubMed ID: 31283911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A positron emission tomography image-guidable unimolecular micelle nanoplatform for cancer theranostic applications.
    Yang J; Lu W; Xiao J; Zong Q; Xu H; Yin Y; Hong H; Xu W
    Acta Biomater; 2018 Oct; 79():306-316. PubMed ID: 30172067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constructing aptamer anchored nanovesicles for enhanced tumor penetration and cellular uptake of water soluble chemotherapeutics.
    Li X; Zhu X; Qiu L
    Acta Biomater; 2016 Apr; 35():269-79. PubMed ID: 26873366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system.
    Akbarzadeh M; Babaei M; Abnous K; Taghdisi SM; Peivandi MT; Ramezani M; Alibolandi M
    Int J Pharm; 2019 Oct; 570():118645. PubMed ID: 31465835
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Zhao Y; Fletcher NL; Liu T; Gemmell AC; Houston ZH; Blakey I; Thurecht KJ
    Nanotheranostics; 2018; 2(4):360-370. PubMed ID: 30324082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localised delivery of doxorubicin to prostate cancer cells through a PSMA-targeted hyperbranched polymer theranostic.
    Pearce AK; Simpson JD; Fletcher NL; Houston ZH; Fuchs AV; Russell PJ; Whittaker AK; Thurecht KJ
    Biomaterials; 2017 Oct; 141():330-339. PubMed ID: 28711780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
    Huang Y; Mao K; Zhang B; Zhao Y
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Robust, active tumor-targeting and fast bioresponsive anticancer nanotherapeutics based on natural endogenous materials.
    Sun B; Deng C; Meng F; Zhang J; Zhong Z
    Acta Biomater; 2016 Nov; 45():223-233. PubMed ID: 27576338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo evaluation of anti-nucleolin-targeted magnetic PLGA nanoparticles loaded with doxorubicin as a theranostic agent for enhanced targeted cancer imaging and therapy.
    Mosafer J; Abnous K; Tafaghodi M; Mokhtarzadeh A; Ramezani M
    Eur J Pharm Biopharm; 2017 Apr; 113():60-74. PubMed ID: 28012991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of theranostic nanomedicine (II): synthesis and physicochemical properties of a biocompatible polyphosphazene-docetaxel conjugate.
    Jun YJ; Park JH; Avaji PG; Park KS; Lee KE; Lee HJ; Sohn YS
    Int J Nanomedicine; 2017; 12():5373-5386. PubMed ID: 28794629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATP/pH Dual Responsive Nanoparticle with d-[des-Arg
    Zhang Y; Lu Y; Wang F; An S; Zhang Y; Sun T; Zhu J; Jiang C
    Small; 2017 Jan; 13(3):. PubMed ID: 27775872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimuli-Responsive Nanotheranostics for Real-Time Monitoring Drug Release by Photoacoustic Imaging.
    Yang Z; Song J; Tang W; Fan W; Dai Y; Shen Z; Lin L; Cheng S; Liu Y; Niu G; Rong P; Wang W; Chen X
    Theranostics; 2019; 9(2):526-536. PubMed ID: 30809290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aptamer-Functionalized and Backbone Redox-Responsive Hyperbranched Polymer for Targeted Drug Delivery in Cancer Therapy.
    Zhuang Y; Deng H; Su Y; He L; Wang R; Tong G; He D; Zhu X
    Biomacromolecules; 2016 Jun; 17(6):2050-62. PubMed ID: 27113017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted SPION siderophore conjugate loaded with doxorubicin as a theranostic agent for imaging and treatment of colon carcinoma.
    Nosrati R; Abnous K; Alibolandi M; Mosafer J; Dehghani S; Taghdisi SM; Ramezani M
    Sci Rep; 2021 Jun; 11(1):13065. PubMed ID: 34158526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodegradable nanotheranostics with hyperthermia-induced bubble ability for ultrasound imaging-guided chemo-photothermal therapy.
    Xu C; Gao F; Wu J; Niu S; Li F; Jin L; Shi Q; Du L
    Int J Nanomedicine; 2019; 14():7141-7153. PubMed ID: 31564870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mn
    Xi J; Da L; Yang C; Chen R; Gao L; Fan L; Han J
    Int J Nanomedicine; 2017; 12():3331-3345. PubMed ID: 28479854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-photon AIE luminogen labeled multifunctional polymeric micelles for theranostics.
    Zhuang W; Ma B; Hu J; Jiang J; Li G; Yang L; Wang Y
    Theranostics; 2019; 9(22):6618-6630. PubMed ID: 31588239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratumoral Distribution and pH-Dependent Drug Release of High Molecular Weight HPMA Copolymer Drug Conjugates Strongly Depend on Specific Tumor Substructure and Microenvironment.
    Noack AK; Lucas H; Chytil P; Etrych T; Mäder K; Mueller T
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 78.